Cardiovascular Systems Stock Z Score
CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Cardiovascular |
Cardiovascular Z Score Analysis
Cardiovascular Systems' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Cardiovascular Systems Z Score | 22.8 |
Most of Cardiovascular Systems' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardiovascular Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, Cardiovascular Systems has a Z Score of 22.8. This is 237.78% higher than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The z score for all United States stocks is 161.47% lower than that of the firm.
Cardiovascular Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardiovascular Systems' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardiovascular Systems could also be used in its relative valuation, which is a method of valuing Cardiovascular Systems by comparing valuation metrics of similar companies.Cardiovascular Systems is currently under evaluation in z score category among related companies.
Cardiovascular Fundamentals
Return On Equity | -0.15 | |||
Return On Asset | -0.0756 | |||
Profit Margin | (0.16) % | |||
Operating Margin | (0.16) % | |||
Current Valuation | 466.13 M | |||
Shares Outstanding | 42.2 M | |||
Shares Owned By Insiders | 3.22 % | |||
Shares Owned By Institutions | 89.64 % | |||
Number Of Shares Shorted | 1.74 M | |||
Price To Earning | 724.24 X | |||
Price To Book | 2.43 X | |||
Price To Sales | 2.51 X | |||
Revenue | 236.22 M | |||
Gross Profit | 172.78 M | |||
EBITDA | (29.96 M) | |||
Net Income | (36.93 M) | |||
Cash And Equivalents | 159.83 M | |||
Cash Per Share | 3.90 X | |||
Total Debt | 22.15 M | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 6.05 X | |||
Book Value Per Share | 5.70 X | |||
Cash Flow From Operations | (24.27 M) | |||
Short Ratio | 2.66 X | |||
Earnings Per Share | (0.96) X | |||
Price To Earnings To Growth | 177.27 X | |||
Target Price | 16.75 | |||
Number Of Employees | 725 | |||
Beta | 0.74 | |||
Market Capitalization | 843.96 M | |||
Total Asset | 322.68 M | |||
Retained Earnings | (320 M) | |||
Working Capital | 69.38 M | |||
Current Asset | 104.88 M | |||
Current Liabilities | 35.5 M | |||
Z Score | 22.8 | |||
Net Asset | 322.68 M |
About Cardiovascular Systems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardiovascular Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardiovascular Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardiovascular Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people.
Pair Trading with Cardiovascular Systems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardiovascular Systems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiovascular Systems will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardiovascular Stock
0.79 | TRV | The Travelers Companies Fiscal Quarter End 31st of March 2024 | PairCorr |
Moving against Cardiovascular Stock
0.87 | BA | Boeing Fiscal Quarter End 31st of March 2024 | PairCorr |
0.61 | AA | Alcoa Corp Fiscal Quarter End 31st of March 2024 | PairCorr |
0.48 | DD | Dupont De Nemours Fiscal Quarter End 31st of March 2024 | PairCorr |
The ability to find closely correlated positions to Cardiovascular Systems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiovascular Systems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiovascular Systems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiovascular Systems to buy it.
The correlation of Cardiovascular Systems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiovascular Systems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiovascular Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardiovascular Systems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |